Voice Outcome Measures for Adult Patients With Unilateral Vocal Fold Paralysis: A Systematic Review.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 04 2018
revised: 14 06 2018
accepted: 18 06 2018
pubmed: 20 9 2018
medline: 18 5 2019
entrez: 20 9 2018
Statut: ppublish

Résumé

Unilateral vocal fold paralysis (UVFP) typically results in marked changes in voice quality and performance and has a significant impact on quality of life. Treatment approaches generally aim to restore glottal closure for phonation and improve vocal function. There are a wide range of voice outcome measures that are available to measure the treatment effect. Careful selection of voice outcome measures is required to ensure that they are adequate for purpose and are psychometrically sound to detect the treatment effect. This article aims to critically evaluate the literature for voice outcome measures that are used for patients with UVFP. Systematic review. Nine databases were searched for UVFP treatment studies published since 2003 (n = 2,484 articles). These articles and their references were screened using inclusion/exclusion criteria, including population characteristics, treatment, voice outcomes, and study findings. Data from the included articles was extracted and appraised with respect to multidimensionality, timing, selection rationale, validity, reliability, and responsiveness to change of the voice outcome measures. A total of 29 studies met the inclusion criteria for the systematic review. These studies showed considerable variability in the rationale, selection, and application of voice outcome measures for reporting the treatment effect for patients with UVFP. There is currently a significant disparity in the selection and use of voice outcome measures for patients with UVFP. A set of principles around selection rationale, validity, reliability, and responsiveness to change is proposed to enhance the judicious selection of voice outcome measures for this patient group. Laryngoscope, 129:187-197, 2019.

Identifiants

pubmed: 30229922
doi: 10.1002/lary.27434
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-197

Subventions

Organisme : Department of Health
ID : NIHR-RP-011-045
Pays : United Kingdom

Informations de copyright

© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Auteurs

Chloe Walton (C)

School of Allied Health, Faculty of Health Sciences, Australian Catholic University (ACU), Brisbane, Australia.

Paul Carding (P)

School of Allied Health, Faculty of Health Sciences, Australian Catholic University (ACU), Brisbane, Australia.

Erin Conway (E)

School of Allied Health, Faculty of Health Sciences, Australian Catholic University (ACU), Brisbane, Australia.

Kieran Flanagan (K)

School of Allied Health, Faculty of Health Sciences, Australian Catholic University (ACU), Brisbane, Australia.

Helen Blackshaw (H)

Ear Institute, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH